

























Veeva Systems Inc. (VEEV) President Matthew J. Wallach Sells 24,000 Shares - BNB Daily





































 
















 

 













Daily Ratings & News for Veeva Systems Inc.
Complete the form below to receive the latest headlines and analysts' recommendationsfor Veeva Systems Inc. with our free daily email newsletter:



 




Follow @bnbdailynews





Recent Posts

Marathon Asset Management LLP Purchases 218,791 Shares of Baidu, Inc. (BIDU)
Express Scripts Holding Company (ESRX) Short Interest Update
Favorable News Coverage Somewhat Unlikely to Impact ILG (ILG) Stock Price
Amgen Inc. (AMGN) Given a $177.00 Price Target at Credit Suisse Group
Insider Selling: Record Plc (REC) Insider Sells 500,000 Shares of Stock
Barrick Gold Corporation (NYSE:ABX) Earns Buy Rating from Royal Bank Of Canada
Insider Selling: Clovis Oncology, Inc. (NASDAQ:CLVS) Insider Sells 3,000 Shares of Stock
Analysts Set Steel Dynamics, Inc. (STLD) Target Price at $38.25
Brokerages Set The Navigators Group, Inc. (NASDAQ:NAVG) Target Price at $56.75
Veeva Systems Inc. (VEEV) President Matthew J. Wallach Sells 24,000 Shares
Energous Corporation (NASDAQ:WATT) Insider Brian J. Sereda Sells 11,395 Shares
Floor & Decor Holdings (FND) Earns Daily News Sentiment Rating of 0.14
SVB Financial Group (SIVB) Earns Buy Rating from Piper Jaffray Companies
Insider Selling: Qualstar Corporation (NASDAQ:QBAK) Major Shareholder Sells 20,000 Shares of Stock
Short Interest in Comcast Corporation (CMCSA) Declines By 22.5%
BMO Capital Markets () Given Consensus Recommendation of “” by Brokerages
Michael Welles Sells 12,388 Shares of Forrester Research, Inc. (FORR) Stock
Varonis Systems, Inc. (VRNS) Insider Sells $665,759.24 in Stock
$0.18 Earnings Per Share Expected for RSP Permian, Inc. (NYSE:RSPP) This Quarter
Grimes & Company Inc. Has $5.74 Million Stake in Gentex Corporation (GNTX)


 


Veeva Systems Inc. (VEEV) President Matthew J. Wallach Sells 24,000 Shares

Posted by Vince Mercandetti on Jul 28th, 2017 // No Comments 

Veeva Systems Inc. (NYSE:VEEV) President Matthew J. Wallach sold 24,000 shares of the firm’s stock in a transaction on Thursday, July 13th. The shares were sold at an average price of $63.15, for a total value of $1,515,600.00. Following the sale, the president now directly owns 24,000 shares of the company’s stock, valued at approximately $1,515,600. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 
Shares of Veeva Systems Inc. (VEEV) traded up 1.90% during midday trading on Friday, reaching $63.68. The company had a trading volume of 334,899 shares. The company has a market capitalization of $8.90 billion, a P/E ratio of 102.54 and a beta of 1.63. The company has a 50-day moving average price of $62.32 and a 200 day moving average price of $53.17. Veeva Systems Inc. has a one year low of $36.06 and a one year high of $68.07. 


 Get Veeva Systems Inc. alerts:



Veeva Systems (NYSE:VEEV) last released its earnings results on Thursday, May 25th. The technology company reported $0.14 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.18 by $0.04. Veeva Systems had a return on equity of 12.28% and a net margin of 15.86%. The business had revenue of $157.90 million during the quarter, compared to analysts’ expectations of $151.82 million. During the same period last year, the business earned $0.15 earnings per share. The company’s revenue for the quarter was up 31.8% compared to the same quarter last year. Equities analysts anticipate that Veeva Systems Inc. will post $0.83 earnings per share for the current fiscal year. 




WARNING: This article was first published by BNB Daily and is the property of of BNB Daily. If you are accessing this article on another website, it was illegally copied and reposted in violation of U.S. and international trademark & copyright legislation. The correct version of this article can be viewed at https://www.baseball-news-blog.com/2017/07/28/veeva-systems-inc-veev-president-matthew-j-wallach-sells-24000-shares-updated.html. 
Hedge funds have recently added to or reduced their stakes in the stock. LS Investment Advisors LLC purchased a new stake in Veeva Systems during the second quarter valued at approximately $105,000. Huntington National Bank raised its stake in Veeva Systems by 10.6% in the second quarter. Huntington National Bank now owns 2,668 shares of the technology company’s stock valued at $164,000 after buying an additional 256 shares during the last quarter. Daiwa Securities Group Inc. purchased a new stake in Veeva Systems during the second quarter valued at approximately $193,000. BNP Paribas Arbitrage SA raised its stake in Veeva Systems by 135.6% in the first quarter. BNP Paribas Arbitrage SA now owns 3,809 shares of the technology company’s stock valued at $195,000 after buying an additional 2,192 shares during the last quarter. Finally, Capstone Asset Management Co. purchased a new stake in Veeva Systems during the second quarter valued at approximately $202,000. 80.52% of the stock is currently owned by hedge funds and other institutional investors. 
VEEV has been the topic of a number of recent analyst reports. Stifel Nicolaus restated a “buy” rating and issued a $67.00 price target (up previously from $60.00) on shares of Veeva Systems in a research report on Sunday, May 21st. Bank of America Corporation upgraded Veeva Systems from a “neutral” rating to a “buy” rating and lifted their target price for the company from $48.00 to $70.00 in a research report on Friday, May 26th. Canaccord Genuity reiterated a “buy” rating and issued a $70.00 target price (up previously from $48.00) on shares of Veeva Systems in a research report on Friday, May 26th. Pacific Crest reissued an “overweight” rating and set a $70.00 price target (up from $61.00) on shares of Veeva Systems in a research note on Sunday, May 28th. Finally, Needham & Company LLC reissued a “buy” rating and set a $75.00 price target (up from $48.00) on shares of Veeva Systems in a research note on Sunday, May 28th. Seven investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $62.00.
Veeva Systems Company Profile
Veeva Systems Inc (Veeva) is a provider of cloud-based software solutions for the global life sciences industry. The Company offers solutions for a range of requirements within life sciences companies, including multichannel customer relationship management, regulated content and information management, master data management and customer data. 

 
Receive News & Ratings for Veeva Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.



 





















Latest News




Leave a Reply

Click here to cancel reply.




Name (Required) 



Mail (will not be published) (Required) 



Website






 






























    Matt Wallach | Veeva Systems Inc | ZoomInfo.com









Wallach Matthew J - Insider Stock Trading - OpenInsider











Sector

All Sectors

Group by Sector


Aerospace
Agriculture
Automobile
Building
Business Services
Chemical
Electrical
Energy
Fashion
Financial
Food & Beverage
Fund
Healthcare
Household
Insurance
Machinery
Media
Metals
Mining
Other
Personal Services
Real Estate
Retail
Technology
Telecom
Transportation
Utility




Industry

All Industries

Group by Industry






Insiders
Filings


All
Purchases
Sales

CIK: 1585819 - Address: C/o Veeva Systems Inc., 4280 Hacienda Drive, Pleasanton, CA 94588 44 results 

						Links
						


SECYahooGoogleFinvizTradingViewStockChartsStockTwitsDownload CSV 













TC
Stat
Stk
Ins
Fil
+d
+w
+m
+q
+h
+y
avg


S%ret11420-01512227S%wins62564342434448 




Filing Date
T Date
Ticker
IssuerInc Sector
IndIndustry
Owner
oSt
Rel
Title
T
TVal
Price
L
Qty
oc
Own
H
r2y
r1y
r6m
r3m
r6w
r3w
r7d
r3d
f1d
f1w
f1m
f3m
f6m
f1y



7/17/17 16:057/13/17VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.d-1,51663.150-24-1000D
6/23/17 16:336/22/17VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.d-1,50862.820-24-1000D
5/11/17 17:535/9/17VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.d-1,32355.1133-24-1000D1051074430117441
4/21/17 17:104/19/17VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.d-1,22551.0633-24-1000D9610237221733313
3/15/17 16:023/13/17VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.d-1,10746.1133-24-1000D85731389543226
2/15/17 17:572/13/17VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.dm-3,68743.8926-84-1000D4610311116210-1-111
1/19/17 17:561/17/17VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.dm-3,62743.1833-84-1000D54802014032-100219
12/9/16 18:5212/7/16VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.dm-3,63143.2233-84-1000D4264288164-81-2-129
11/30/16 16:0311/7/16VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.adm-3,24338.6133-84-1000D446441262322132-6-7-11-5
11/9/16 17:2311/7/16VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.dm-3,24338.6133-84-1000D3744421-7033-12101142
10/17/16 16:1110/13/16VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.dm-3,19338.0133-84-1000D4248473-7-8-601251433
9/29/16 16:149/27/16VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.dm-3,48341.4733-84-1000D4483662361400-3-9023
8/8/16 16:028/4/16VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.dm-3,17537.7933-84-1000D6850704111422036-213
7/21/16 18:257/19/16VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.dm-3,05136.3333-84-1000D4733514047-102310619
6/13/16 16:016/9/16VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.dm-2,91934.7533-84-1000D5725282724181-4-1-191828
5/6/16 16:075/4/16VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.dm-2,25426.8326-84-1000D38-221084-1-411303941
4/18/16 16:244/14/16VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.dm-2,17325.8726-84-1000D16-553-47-210584147
3/23/16 16:323/21/16VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.dm-2,15125.6027-84-1000D-15-3-3-8220-42128376495
3/1/16 18:182/23/16VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.adm-1,86722.2228-84-1000D-32-211-15-11510739-1295777
2/25/16 16:582/23/16VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.dm-1,86722.2228-84-1000D-36-24-3-17-11-4922128297491
1/29/16 16:321/27/16VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.dm-1,98223.5933-84-1000D-26-20-15-8-16-12-4-6111155980
1/7/16 19:0612/28/15VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.adm-2,41928.8031-84-1000D-19411533-3-3-2-7-14-13754
12/30/15 21:4712/28/15VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.dm-2,42328.8427-84-1000D-9832777400-3-17-141843
11/9/15 19:1911/5/15VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.dm-2,23326.5818-84-1000D-30-2-1417443-1-20-22144
10/8/15 18:3010/6/15VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.dm-2,06324.5727-84-1000D-2-6-107-5842-244155
9/23/15 18:569/21/15VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.dm-2,20326.2327-84-1000D-11-5-9151-3-2-9-111-264
8/7/15 16:498/5/15VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.dm-2,19126.0821-84-1000D12-15-6-10-10-6-32-2-33-1249
7/20/15 16:467/16/15VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.dm-2,39528.5133-84-1000D19172-11-2-1-1-8-8-1231
6/29/15 21:156/25/15VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.dm-2,36128.1033-84-1000D18612565100-3-13317
5/26/15 16:245/21/15VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.dm-2,34627.9316-84-1000D392-75242-3-8-1-15-53
4/22/15 17:554/20/15VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.dm-2,24226.6923-84-1000D22-4-41151-11121-4-4
4/8/15 19:283/2/15VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.d-1,87031.0233-60-1000D13-5-1-13-6340-127-8-1
3/30/15 16:543/26/15VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.dm-2,13825.4533-84-1000D-2-11-5-153-7-701712-5-2
2/5/15 17:462/4/15VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.d-1,27730.0020-43-1000D029484140-1-18-10-12-19
2/4/15 20:032/2/15VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.dm-2,39228.4720-84-1000D027-1611100-18-12-13-22
1/5/15 18:281/2/15VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.d-2,20626.2631-84-1000D-195-3-4-9-5-231012-269
12/3/14 18:2212/1/14VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.d-1,85431.4127-59-1000D-24599101013-342-13-18-9-6
11/5/14 18:1411/3/14VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.dm-2,42028.8121-84-1000D-275925-271-1-12127-4-6
10/8/14 17:0710/2/14VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.ad-2,29526.6031-86-1000D1073-12-11-5-2-1852-4
10/3/14 16:0310/1/14VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.dm-3,75326.8833-140-1000D9819-14-7-6-4-79-5-7-12
10/3/14 16:0310/1/14VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.dm-3,75326.8833-140-1000D9819-14-7-6-4-79-5-7-12
9/4/14 17:479/2/14VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.d-4,00529.0833-138-1000D-174622261816-12-114-19-19
7/3/14 16:137/1/14VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.d-1,42125.3833-56-1000D-21-42815320-3-1010612
10/23/13 21:2510/21/13VEEVVeeva Systems IncTechSoftwPrepackaged SoftwareWallach Matthew JCAOPS.d-10,00020.0033-500-1000M38-3-7-20-45-29



DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing



S - SaleSale of securities on an exchange or to another person

S - Sale+OESale of securities on an exchange or to another person (after option exercise)

F - TaxPayment of exercise price or tax liability using portion of securities received from the company

P - PurchasePurchase of securities on an exchange or from another person


Return to top
Contact
Copyright © 2017 OpenInsider.com. All rights reserved.















 





Matthew  Wallach in          Villanova, PA
    | Intelius






















Sign In




People Search
Background Check
Criminal Records
Reverse Lookup
Employee Screening
Identity Protection
Intelius Premier




Reverse Lookup
People Search






We did not find Matthew  Wallach in          Villanova, PA
   


         Intelius is a leading provider of public data about people and their connections to others. Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the Fair Credit Reporting Act (FCRA). This site should not be used to determine an individual’s eligibility for credit, insurance, employment, housing or any other purpose covered by the FCRA. For employment or tenant screening services, please visit our partner Talentwise.
      

About Us
Site Map
About Our Reports
Blog
Help
Contact Us

© 2003 – 2017 PeopleConnect, Inc. d/b/a Intelius. All Rights Reserved.
         Privacy Policy - UPDATED
Terms of Service - UPDATED






What is the FCRA?
The Fair Credit Reporting Act ("FCRA") is a federal law that promotes the accuracy, fairness and privacy of information in the files of consumer reporting agencies.
Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the FCRA. Intelius reports cannot be used for background checks related to consumer credit, insurance, employment, housing or any other purpose
                  prohibited under the FCRA.
You may not use any information obtained from Intelius for any purpose covered by the FCRA.
Find out more about the FCRA here.













Matthew J. Wallach: Executive Profile & Biography - Bloomberg









































  





















































































July 29, 2017 2:00 AM ET
Health Care Technology

Company Overview of Veeva Systems Inc.



SnapshotPeople 




OverviewBoard MembersCommittees



Executive Profile
Matthew J. Wallach  Co-Founder and President, Veeva Systems Inc.AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 3 different industries.See Board Relationships45--As of Fiscal Year 2015
Background

		Mr. Matthew J. Wallach, also known as Matt, serves as President of Veeva Systems, Inc. Mr. Wallach co-founded the firm in 2007.  He also served as an Executive Vice President and General Manager at the firm. He served as Chief Strategy Officer of Veeva Systems Inc. from September 2010 to August 2013. He was responsible for all aspects of sales, marketing and business development of the company. Previously at Veeva, Mr. Wallach served as the Vice President of Sales and ... Marketing and Director. He served as the Vice President of Marketing and Strategic Product Management at Symyx Software Inc. from January 2004 to December 2004. Mr. Wallach led the global marketing and product management teams and was responsible for ensuring that products deliver tangible business benefits. He joined the firm in January 2004. He served as the Chief Marketing Officer of Health Market Science Inc., where he was responsible for setting the future product and technology direction of Health Market. Prior to that, Mr. Wallach was Vice President of Marketing and Product Management at IntelliChem. He was the General Manager of Pharmaceuticals and Biotechnology division of Siebel Systems, where he was responsible for building this global division. Mr. Wallach started his career at Booz Allen & Hamilton, where he was a management consultant focusing on the chemicals and pharmaceuticals industries. He is a Member of Advisory Board of SeventySix Capital, Crossix and Everypath Inc. Mr. Wallach has ten years of software product management, marketing and general management experience. In 2007, Mr. Wallach was named in the PharmaVOICE 100 recognizing him as one of the 100 most influential people in the life sciences industry. He holds an M.B.A. from Harvard Business School and a B.A. in Economics from Yale University Cum Laude.Read Full Background




Corporate Headquarters
4280 Hacienda DrivePleasanton, California 94588United StatesPhone: 925-452-6500Fax: 925-452-6504
Board Members Memberships
				There is no Board Members Memberships data available.
				Education
MBA Harvard Business SchoolBA Yale University
Other Affiliations
Everypath, Inc.SeventySix CapitalHarvard Business SchoolYale UniversitySymyx Software, Inc.Health Market Science, Inc.


Annual Compensation
				There is no Annual Compensation data available.
				Stocks Options
				There is no Stock Options data available.
				Total Compensation
				There is no Total Compensation data available.
			



Request Profile Update
















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



COMPETITOR COMPENSATIONNamePosition/CompanyCompensationRobert P. Carrigan Chairman & Chief Executive OfficerThe Dun & Bradstreet Corporation$850.0KJosef H. von Rickenbach Founder, Chairman and Chief Executive OfficerPAREXEL International Corporation$1.6MMark J. Barrenechea CEO, CTO & Non Independent DirectorOpen Text Corporation$945.0KRobert W. Musslewhite J.D.Chairman and Chief Executive OfficerThe Advisory Board Company$650.0KTarek A. Sherif Co-Founder, Chairman and Chief Executive OfficerMedidata Solutions, Inc.$568.3KCompensation as of Fiscal Year 2016.










Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Veeva Systems Inc., please visit .  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close



































Matthew J. Wallach - Executive Bio, Compensation History, and Contacts - Equilar Atlas










 

















Log in | Sign up








x

 






As Featured In



















Matthew J. Wallach
President at Veeva Systems Inc.


View Full Profile
Are you Matthew J. Wallach? Claim your profile


 


Sign up for Equilar Atlas and view Matthew J. Wallach's full profile. 
With Equilar Atlas, you can:



IDENTIFY corporate executives in Matthew J. Wallach's  network and community.
												FOLLOW changes in Matthew J. Wallach's employment and money-in-motion.
												CONNECT with Matthew J. Wallach through your network of contacts.
												








Matthew J. Wallach's Executive Work History


Current


President, 
Veeva Systems Inc.


Past
To view Matthew J. Wallach's complete executive work history, sign up now
Age
44

 
 


Matthew J. Wallach's Biography



Matthew J. Wallach is one of our founders and has served in various senior executive roles since joining Veeva in March 2007. He currently serves as our President and prior to that served as our Chief Strategy Officer from September 2010 to August 2013. Between April 2005 and March 2007, Mr. Wallach served as Chief Marketing Officer at Health Market Science, Inc., a supplier of healthcare data solutions. From January 2004 to December 2004, Mr. Wallach served as Vice President of Marketing and Product Management at IntelliChem, Inc., a provider of scientific content management solutions. Mr. Wallach was previously the General Manager of the Ph ...
(Read More)

			Matthew J. Wallach is one of our founders and has served in various senior executive roles since joining Veeva in March 2007. He currently serves as our President and prior to that served as our Chief Strategy Officer from September 2010 to August 2013. Between April 2005 and March 2007, Mr. Wallach served as Chief Marketing Officer at Health Market Science, Inc., a supplier of healthcare data solutions. From January 2004 to December 2004, Mr. Wallach served as Vice President of Marketing and Product Management at IntelliChem, Inc., a provider of scientific content management solutions. Mr. Wallach was previously the General Manager of the Pharmaceuticals & Biotechnology division at Siebel Systems, Inc., a customer relationship management software company, from August 1998 to December 2003. Mr. Wallach earned a Bachelor of Arts degree in Economics from Yale University and a Master of Business Administration from the Harvard Business School.
		
Source: Veeva Systems Inc. on 05/05/2015
		
	

 






Sign up for Equilar Atlas and view Matthew J. Wallach's full profile. 



												By accessing Equilar Atlas, you can view bios, network, salary and wealth events
												of industry-leading executives like Matthew J. Wallach. More specifically, you'll be able to:
												

IDENTIFY corporate executives in Matthew J. Wallach's  network and community.
												FOLLOW changes in Matthew J. Wallach's employment and money-in-motion.
												CONNECT with Matthew J. Wallach through your network of conections.
												




View Full Profile


 








Search for over 360,000 executive profiles.





/bio



													Example: Matthew J. Wallach


















Matthew J. Wallach's Connections (14)





Sign up now to view Matthew J. Wallach's 14 connections »









Ronald E. Codd
Board Member, ServiceNow, Inc.









Paul E. Chamberlain
Board Member, TriNet Group, Inc.









Frederic Lequient
Senior Vice President, Global Customer Services, Veeva Systems Inc.









Paul J. Sekhri
Board Member, Veeva Systems Inc.









Jonathan W. Faddis
Senior Vice President, General Counsel and Corporate Secretary, Veeva Systems Inc.









Frank Defesche
Senior Vice President and General Manager, Vault QualityOne, Veeva Systems Inc.









Timothy C. Barabe
Board Member, ArQule, Inc.









Peter P. Gassner
Dir. and Chief Executive Officer, Veeva Systems Inc.









Eleni N. Zuppas
Chief Marketing Officer, Veeva Systems Inc.









Timothy S. Cabral
Chief Financial Officer, Veeva Systems Inc.








Popular Profiles






														Sign up now to view more executive profiles »
														









Thomas J. Lynch
Executive Chairman, TE Connectivity Ltd.









John J. Kita
EVP and CFO, A. O. Smith









Carl G. Annessa
EVP and COO, Hornbeck Offshore Services, Inc.









Elon R. Musk
CEO and Chairman, Tesla









Michael C. Montgomery
Board Member, NMI Holdings, Inc.












×

Claim Your Profile Coming Soon
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.

Done


Thank you for your interest.
Ok






			Browse executive profiles:
			
				 A
			
				 B
			
				 C
			
				 D
			
				 E
			
				 F
			
				 G
			
				 H
			
				 I
			
				 J
			
				 K
			
				 L
			
				 M
			
				 N
			
				 O
			
				 P
			
				 Q
			
				 R
			
				 S
			
				 T
			
				 U
			
				 V
			
				 W
			
				 X
			
				 Y
			
				 Z



Equilar Homepage
Equilar Atlas
Equilar Insight
Equilar BoardEdge
Equilar Engage
Research Services
Knowledge Network
About Us
Login

ï¿½ 2017 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993
















VEEV Matthew J. Wallach Insider Trades for Veeva Systems Inc. Cl A


































Bulletin






Investor Alert





















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Veeva Systems Inc. Cl A

                  NYSE: VEEV
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Veeva Systems Inc. Cl A



After Hours
 --Quotes are delayed by 20 min
Jul 28, 2017, 4:42 p.m.


VEEV

/quotes/zigman/21690485/composite


$
63.41




Change

-0.22
-0.35%

Volume
Volume 135,125
Quotes are delayed by 20 min








/quotes/zigman/21690485/composite
Previous close

$
			62.49
		


$
				63.63
			
Change

+1.14
+1.82%





Day low
Day high
$61.86
$64.24










52 week low
52 week high

            $36.55
        

            $68.07
        


















Insider Activity


Individual




Matthew J. Wallach



Mr. Matt Wallach is Chief Strategy Officer at Veeva Systems, Inc. and an Advisory Board Member at A&I Ventures (Formerly known as SeventySix Capital LLC).
Mr. Wallach was previously employed as Chief Marketing Officer at Health Market Science, Inc., General Manager-Pharmaceuticals & Biotechnology at Siebel Systems, Inc., Vice President-Marketing at Everypath, Inc., and Vice President-Marketing & Prroduct Management at IntelliChem, Inc.
Mr. Wallach received his undergraduate degree from Yale University and an MBA from Harvard University.



Transactions


Date
Shares
Transaction
Value





07/13/2017
670


 
Disposition at $63.61 per share.


42,619


07/13/2017
23,330


 
Disposition at $63.13 per share.


1,472,823


07/13/2017
24,000


 
Derivative/Non-derivative trans. at $0 per share.


0


06/22/2017
4,100


 
Disposition at $63.14 per share.


258,874


06/22/2017
19,900


 
Disposition at $62.76 per share.


1,248,924


06/22/2017
24,000


 
Derivative/Non-derivative trans. at $0 per share.


0


05/22/2017
4,750


 
Gift at $0 per share.


0


05/22/2017
4,750


 
Derivative/Non-derivative trans. at $0 per share.


0


05/09/2017
24,000


 
Disposition at $55.11 per share.


1,322,640


05/09/2017
24,000


 
Derivative/Non-derivative trans. at $0 per share.


0


04/19/2017
24,000


 
Disposition at $51.06 per share.


1,225,440


04/19/2017
24,000


 
Derivative/Non-derivative trans. at $0 per share.


0


04/11/2017
2,000


 
Gift at $0 per share.


0


04/11/2017
2,000


 
Derivative/Non-derivative trans. at $0 per share.


0


03/13/2017
13,400


 
Disposition at $46.36 per share.


621,224


03/13/2017
10,600


 
Disposition at $45.8 per share.


485,480


03/13/2017
24,000


 
Derivative/Non-derivative trans. at $0 per share.


0


02/14/2017
60,289


 
Disposition at $43.8 per share.


2,640,659


02/14/2017
60,289


 
Derivative/Non-derivative trans. at $0 per share.


0


02/13/2017
23,711


 
Disposition at $44.12 per share.


1,046,130


02/13/2017
23,711


 
Derivative/Non-derivative trans. at $0 per share.


0


01/18/2017
42,000


 
Disposition at $42.93 per share.


1,803,060


01/18/2017
42,000


 
Derivative/Non-derivative trans. at $0 per share.


0


01/17/2017
300


 
Disposition at $44.08 per share.


13,224


01/17/2017
41,700


 
Disposition at $43.43 per share.


1,811,031


01/17/2017
42,000


 
Derivative/Non-derivative trans. at $0 per share.


0


12/27/2016
50,000


 
Gift at $0 per share.


0


12/27/2016
50,000


 
Derivative/Non-derivative trans. at $0 per share.


0


12/22/2016
6,000


 
Gift at $0 per share.


0


12/22/2016
6,000


 
Derivative/Non-derivative trans. at $0 per share.


0


12/08/2016
4,600


 
Disposition at $43.74 per share.


201,204


12/08/2016
37,400


 
Disposition at $43.42 per share.


1,623,908


12/08/2016
42,000


 
Derivative/Non-derivative trans. at $0 per share.


0


12/07/2016
42,000


 
Disposition at $42.99 per share.


1,805,580


12/07/2016
42,000


 
Derivative/Non-derivative trans. at $0 per share.


0


11/08/2016
60,289


 
Disposition at $38.58 per share.


2,325,950


11/08/2016
60,289


 
Derivative/Non-derivative trans. at $0 per share.


0


11/07/2016
3,611


 
Disposition at $39.05 per share.


141,010


11/07/2016
20,100


 
Disposition at $38.63 per share.


776,463


11/07/2016
23,711


 
Derivative/Non-derivative trans. at $0 per share.


0


10/14/2016
42,000


 
Disposition at $38.16 per share.


1,602,720


10/14/2016
42,000


 
Derivative/Non-derivative trans. at $0 per share.


0


10/13/2016
1,545


 
Disposition at $38.13 per share.


58,911


10/13/2016
40,455


 
Disposition at $37.86 per share.


1,531,627


10/13/2016
42,000


 
Derivative/Non-derivative trans. at $0 per share.


0


09/28/2016
42,000


 
Disposition at $41.62 per share.


1,748,040


09/28/2016
42,000


 
Derivative/Non-derivative trans. at $0 per share.


0


09/27/2016
42,000


 
Disposition at $41.31 per share.


1,735,020


09/27/2016
42,000


 
Derivative/Non-derivative trans. at $0 per share.


0


08/05/2016
60,289


 
Disposition at $37.93 per share.


2,286,762


08/05/2016
60,289


 
Derivative/Non-derivative trans. at $0 per share.


0


08/04/2016
23,711


 
Disposition at $37.45 per share.


887,977


08/04/2016
23,711


 
Derivative/Non-derivative trans. at $0 per share.


0


07/20/2016
42,000


 
Disposition at $36.5 per share.


1,533,000


07/20/2016
42,000


 
Derivative/Non-derivative trans. at $0 per share.


0


07/19/2016
42,000


 
Disposition at $36.15 per share.


1,518,300


07/19/2016
42,000


 
Derivative/Non-derivative trans. at $0 per share.


0


06/28/2016
50


 
Gift at $0 per share.


0


06/28/2016
50


 
Derivative/Non-derivative trans. at $0 per share.


0


06/10/2016
42,000


 
Disposition at $34.34 per share.


1,442,280


06/10/2016
42,000


 
Derivative/Non-derivative trans. at $0 per share.


0


06/09/2016
42,000


 
Disposition at $35.16 per share.


1,476,720


06/09/2016
42,000


 
Derivative/Non-derivative trans. at $0 per share.


0


06/03/2016
4,250


 
Gift at $0 per share.


0


06/03/2016
4,250


 
Derivative/Non-derivative trans. at $0 per share.


0


05/05/2016
60,289


 
Disposition at $26.84 per share.


1,618,157


05/05/2016
60,289


 
Derivative/Non-derivative trans. at $0 per share.


0


05/04/2016
23,711


 
Disposition at $26.8 per share.


635,455


05/04/2016
23,711


 
Derivative/Non-derivative trans. at $0 per share.


0


04/15/2016
42,000


 
Disposition at $25.52 per share.


1,071,840


04/15/2016
42,000


 
Derivative/Non-derivative trans. at $0 per share.


0


04/14/2016
42,000


 
Disposition at $26.21 per share.


1,100,820


04/14/2016
42,000


 
Derivative/Non-derivative trans. at $0 per share.


0


03/22/2016
42,000


 
Disposition at $25.59 per share.


1,074,780


03/22/2016
42,000


 
Derivative/Non-derivative trans. at $0 per share.


0


03/21/2016
42,000


 
Disposition at $25.62 per share.


1,076,040


03/21/2016
42,000


 
Derivative/Non-derivative trans. at $0 per share.


0


02/24/2016
4,807


 
Disposition at $22.63 per share.


108,783


02/24/2016
4,807


 
Disposition at $22.63 per share.


108,783


02/24/2016
39,000


 
Disposition at $22.11 per share.


862,290


02/24/2016
39,000


 
Disposition at $22.11 per share.


862,290


02/24/2016
43,807


 
Derivative/Non-derivative trans. at $0 per share.


0


02/24/2016
43,807


 
Derivative/Non-derivative trans. at $0 per share.


0


02/23/2016
40,193


 
Disposition at $22.29 per share.


895,902


02/23/2016
40,193


 
Disposition at $22.29 per share.


895,902


02/23/2016
40,193


 
Derivative/Non-derivative trans. at $0 per share.


0


02/23/2016
40,193


 
Derivative/Non-derivative trans. at $0 per share.


0


01/28/2016
100


 
Disposition at $23.88 per share.


2,388


01/28/2016
41,900


 
Disposition at $23.15 per share.


969,985


01/28/2016
42,000


 
Derivative/Non-derivative trans. at $0 per share.


0


01/27/2016
42,000


 
Disposition at $24.03 per share.


1,009,260


01/27/2016
42,000


 
Derivative/Non-derivative trans. at $0 per share.


0


12/29/2015
23,711


 
Derivative/Non-derivative trans. at $0 per share.


0


12/29/2015
23,711


 
Disposition at $28.87 per share.


684,537


12/28/2015
60,289


 
Disposition at $28.78 per share.


1,735,118


12/28/2015
60,289


 
Derivative/Non-derivative trans. at $0 per share.


0


12/22/2015
2,500


 
Gift at $0 per share.


0


12/22/2015
2,500


 
Derivative/Non-derivative trans. at $0 per share.


0


11/06/2015
42,000


 
Disposition at $26.86 per share.


1,128,120


11/06/2015
42,000


 
Derivative/Non-derivative trans. at $0 per share.


0


11/05/2015
42,000


 
Disposition at $26.31 per share.


1,105,020


11/05/2015
42,000


 
Derivative/Non-derivative trans. at $0 per share.


0


10/07/2015
42,000


 
Disposition at $24.85 per share.


1,043,700


10/07/2015
42,000


 
Derivative/Non-derivative trans. at $0 per share.


0


10/06/2015
42,000


 
Disposition at $24.28 per share.


1,019,760


10/06/2015
42,000


 
Derivative/Non-derivative trans. at $0 per share.


0


09/22/2015
23,711


 
Disposition at $25.81 per share.


611,981


09/22/2015
23,711


 
Derivative/Non-derivative trans. at $0 per share.


0


09/21/2015
60,289


 
Disposition at $26.39 per share.


1,591,027


09/21/2015
60,289


 
Derivative/Non-derivative trans. at $0 per share.


0


08/06/2015
2,900


 
Disposition at $26.16 per share.


75,864


08/06/2015
39,100


 
Disposition at $25.65 per share.


1,002,915


08/06/2015
42,000


 
Derivative/Non-derivative trans. at $0 per share.


0


08/05/2015
42,000


 
Disposition at $26.47 per share.


1,111,740


08/05/2015
42,000


 
Derivative/Non-derivative trans. at $0 per share.


0


07/17/2015
42,000


 
Disposition at $28.28 per share.


1,187,760


07/17/2015
42,000


 
Derivative/Non-derivative trans. at $0 per share.


0


07/16/2015
42,000


 
Disposition at $28.74 per share.


1,207,080


07/16/2015
42,000


 
Derivative/Non-derivative trans. at $0 per share.


0


07/06/2015
2,500


 
Gift at $0 per share.


0


07/06/2015
2,500


 
Derivative/Non-derivative trans. at $0 per share.


0


06/26/2015
23,710


 
Disposition at $28.29 per share.


670,756


06/26/2015
23,710


 
Derivative/Non-derivative trans. at $0 per share.


0


06/25/2015
60,290


 
Disposition at $28.03 per share.


1,689,929


06/25/2015
60,290


 
Derivative/Non-derivative trans. at $0 per share.


0


05/22/2015
42,000


 
Disposition at $27.96 per share.


1,174,320


05/22/2015
42,000


 
Derivative/Non-derivative trans. at $0 per share.


0


05/21/2015
42,000


 
Disposition at $27.9 per share.


1,171,800


05/21/2015
42,000


 
Derivative/Non-derivative trans. at $0 per share.


0


04/21/2015
42,000


 
Disposition at $26.71 per share.


1,121,820


04/21/2015
42,000


 
Derivative/Non-derivative trans. at $0 per share.


0


04/20/2015
42,000


 
Disposition at $26.67 per share.


1,120,140


04/20/2015
42,000


 
Derivative/Non-derivative trans. at $0 per share.


0


04/08/2015
200


 
Gift at $0 per share.


0


04/08/2015
200


 
Derivative/Non-derivative trans. at $0 per share.


0


03/27/2015
42,000


 
Disposition at $25.38 per share.


1,065,960


03/27/2015
42,000


 
Derivative/Non-derivative trans. at $0 per share.


0


03/26/2015
42,000


 
Disposition at $25.51 per share.


1,071,420


03/26/2015
42,000


 
Derivative/Non-derivative trans. at $0 per share.


0


03/02/2015
60,289


 
Disposition at $31.02 per share.


1,870,165


03/02/2015
60,289


 
Derivative/Non-derivative trans. at $0 per share.


0


02/04/2015
42,566


 
Disposition at $30 per share.


1,276,980


02/04/2015
42,566


 
Derivative/Non-derivative trans. at $0 per share.


0


02/03/2015
12,739


 
Disposition at $28.56 per share.


363,826


02/03/2015
12,739


 
Derivative/Non-derivative trans. at $0 per share.


0


02/02/2015
71,261


 
Disposition at $28.46 per share.


2,028,089


02/02/2015
71,261


 
Derivative/Non-derivative trans. at $0 per share.


0


01/02/2015
84,000


 
Disposition at $26.26 per share.


2,205,840


01/02/2015
84,000


 
Derivative/Non-derivative trans. at $0 per share.


0


12/01/2014
4,414


 
Disposition at $32.11 per share.


141,734


12/01/2014
54,600


 
Disposition at $31.35 per share.


1,711,710


12/01/2014
59,014


 
Derivative/Non-derivative trans. at $0 per share.


0


11/04/2014
34,000


 
Disposition at $28.4 per share.


965,600


11/04/2014
34,000


 
Derivative/Non-derivative trans. at $0 per share.


0


11/03/2014
7,600


 
Disposition at $29.71 per share.


225,796


11/03/2014
42,400


 
Disposition at $28.98 per share.


1,228,752


11/03/2014
50,000


 
Derivative/Non-derivative trans. at $0 per share.


0


10/02/2014
85,880


 
Disposition at $26.6 per share.


2,284,408


10/02/2014
85,880


 
Derivative/Non-derivative trans. at $0 per share.


0


10/02/2014
86,283


 
Disposition at $26.6 per share.


2,295,128


10/02/2014
86,283


 
Derivative/Non-derivative trans. at $0 per share.


0


10/01/2014
521


 
Disposition at $28.12 per share.


14,651


10/01/2014
521


 
Disposition at $28.12 per share.


14,651


10/01/2014
53,196


 
Disposition at $27.33 per share.


1,453,847


10/01/2014
53,196


 
Disposition at $27.33 per share.


1,453,847


10/01/2014
53,717


 
Derivative/Non-derivative trans. at $0 per share.


0


10/01/2014
53,717


 
Derivative/Non-derivative trans. at $0 per share.


0


09/25/2014
2,333


 
Gift at $0 per share.


0


09/25/2014
2,333


 
Derivative/Non-derivative trans. at $0 per share.


0


09/02/2014
39,156


 
Disposition at $29.51 per share.


1,155,494


09/02/2014
98,542


 
Disposition at $28.91 per share.


2,848,850


09/02/2014
137,698


 
Derivative/Non-derivative trans. at $0 per share.


0


07/01/2014
56,000


 
Disposition at $25.38 per share.


1,421,280


07/01/2014
56,000


 
Derivative/Non-derivative trans. at $0 per share.


0


05/13/2014
5,758


 
Derivative/Non-derivative trans. at $0 per share.


0


10/21/2013
500,000


 
Disposition at $20 per share.


10,000,000


10/21/2013
500,000


 
Derivative/Non-derivative trans. at $0 per share.


0


10/21/2013
300,000


 



0


10/21/2013
300,000


 



0


10/21/2013
2,900,000


 



0





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Mr. Gordon  Ritter 
Chairman




Mr. Peter P. Gassner 
Chief Executive Officer & Director




Mr. Matthew J. Wallach 
President




Mr. Mitch  Wallace 
Vice President-Operations




Mr. Timothy Stephen  Cabral 
Chief Financial Officer




Mr. Doug  Ostler 
Vice President-CRM Products & Technology




Mr. Henry  Levy 
Chief Strategy Officer




Mr. Dan  Goldsmith 
Chief Strategy Officer




Dr. Jacques  Mourrain 
Senior Director-Quality & Compliance




Ms. Avril  England 
General Manager-Veeva Vault




Mr. Steve  Harper 
Director-Product Management Vault Platform




Mr. Mark T. Carges 
Director




Mr. Paul  Shawah 
Senior Vice President-Commercial Strategy




Ms. Eleni Nitsa Zuppas 
Chief Marketing Officer & Head-Media Contacts




Mr. Alan V. Mateo 
Executive Vice President-Global Sales




Mr. Rick  Lund 
Director-Investor Relations




Ms. Lisa  Barbadora 
Head-Public Relations




Mr. Jonathan  Faddis 
Secretary, Senior Vice President & General Counsel




Mr. Paul E. Chamberlain 
Independent Director




Mr. Paul Jai Sekhri 
Independent Director




Mr. Ronald E. F. Codd 
Independent Director




Mr. Timothy C. Barabe 
Independent Director









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/65801738/composite TLT+1.11%


/quotes/zigman/59386294/composite JNUG-5.94%


X




Powered by














Log In




2:00 AM EDT
July 29, 2017


/marketstate/country/us
New York

	Closed


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
12:34aBREAKINGElon Musk details Tesla Model 3 pricing, range
12:21aTesla: Standard Model 3 will cost $35,000, long-range model will cost $44,000
9:16pWall Street isn’t ready for a 1,100-point tumble in the Dow industrials
7:39pBarron's Buzz: Robo 2.0, Facebook and Twitter, Trading On News
7:29pA Wild Week in Washington 
6:32pThe dark side of cruises
6:32pThe highest paid athletes in the world, in one chart
6:31pO.J. Simpson made over $400,000 while in prison and won’t have to give any of it to the Goldman family
6:31p Trump to Police: 'Don't Be Too Nice'
6:31pHere are 10 co-workers you should avoid like the plague — especially in meetings
6:29pTop 10 most annoying people you may want to unfriend on Facebook 
6:29pThis is one person you should never unfriend on Facebook...
6:29p3 horrible ways typos could alter the course of your life
6:27pPaint your bathroom this color and boost your home’s selling price by $5,400
6:27pAmericans’ new badge of honor: ‘I was blocked by a celebrity!’
6:27p5 weird things I found out about America in my first 24 hours 
6:14pBeyond Tesla: 7 stocks driving the autonomous car revolution
6:14pThese 7 highly taxed companies need Congress to finally act on tax reform
6:11pWatch out: ‘Kids’ are making the most money in this stock market 
6:10p7 real ways for millennials to save money (not by brownbagging and skipping Starbucks)
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,830.31

+33.76
+0.15%





nasdaq

/quotes/zigman/12633936/realtime
6,374.68

-7.51
-0.12%





s&p 500

/quotes/zigman/3870025/realtime
2,472.10

-3.32
-0.13%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15

























































Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft







































Matthew J. Wallach Sells 24000 Shares of Veeva Systems Inc


































Contacts






 

July 29, 2017 
							


















Economy


Culture


Sci-tech


Science


Sport


Worldwide


Health Care


Local















Matthew J. Wallach sold $3.63M worth of shares in Veeva Systems, Inc. in December 2016


























































                      NEWS HOME
                    

Advertising
Board and Executive Moves
Energy
Health Care
Hedge Funds
M & A
Private Equity
Technology














        Matthew J. Wallach sold $3.63M worth of shares in Veeva Systems, Inc. in December 2016    























































































































Email







LinkedIn







Facebook







Google+







Tweet







Reddit





Permalink



 

          Jan 8, 2017                         - RelSci Data Update                

          Insider Transactions      




Background Information:


Matthew J. Wallach »
Co-Founder, President at Veeva Systems, Inc.


Career:




                                                                Veeva Systems, Inc.                                                            







                                                                National Association of Independent Schools                                                            







                                                                Health Market Science, Inc.                                                            





Boards:




                                                                Healthverity, Inc.                                                            







                                                                A&I Ventures                                                            







                                                                Crossix Solutions, Inc.                                                            





Education:




                                                                Yale University                                                            







                                                                Harvard University - Harvard Business School                                                            







In The News:




                            HealthVerity Completes Series B Financing of $10 Million                            


                            April 25, 2017  •  Business Wire                        





                            Veeva Global Commercial & Medical Summit to Feature Seven of the Top 10 Largest Pharmaceutical Companies and Leading Biotechs                            


                            April 18, 2017  •  Business Wire                        





                            Veeva to Present at the J.P. Morgan Healthcare Conference                            


                            January 5, 2017  •  Business Wire                        









Matthew J. Wallach »
Co-Founder, President at Veeva Systems, Inc.






Career:

•


                                                                                    Veeva Systems, Inc.                                                                                    



•


                                                                                    National Association of Independent Schools                                                                                    



•


                                                                                    Health Market Science, Inc.                                                                                    




Boards:

•


                                                                                    Healthverity, Inc.                                                                                    



•


                                                                                    A&I Ventures                                                                                    



•


                                                                                    Crossix Solutions, Inc.                                                                                    




Education:

•


                                                                                    Yale University                                                                                    



•


                                                                                    Harvard University - Harvard Business School                                                                                    







In The News:




 


                                                    HealthVerity Completes Series B Financing of $10 Million                                                





                                     April 25, 2017  •  Business Wire                                





 


                                                    Veeva Global Commercial & Medical Summit to Feature Seven of the Top 10 Largest Pharmaceutical Companies and Leading Biotechs                                                





                                     April 18, 2017  •  Business Wire                                





 


                                                    Veeva to Present at the J.P. Morgan Healthcare Conference                                                





                                     January 5, 2017  •  Business Wire                                








Veeva Systems, Inc. »
Veeva Systems, Inc. provides industry-specific, cloud-based software solutions for the life sciences industry. Its solutions enable pharmaceutical and other life sciences companies to realize the benefits of modern cloud-based architectures and mobile applications for their most critical business functions, without compromising industry-specific functionality or regulatory compliance. The company's customer relationship management solutions enable its customers to increase the productivity and compliance of their sales and marketing functions. Its regulated content management and collaboration solutions enable its customers to more efficiently manage a regulated, content-centric processes across the enterprise. The company's customer master solution enables customers to more effectively manage complex healthcare provider and healthcare organization data. Veeva Systems was founded by Mark Armenante, Peter P. Gassner, Doug Ostler, Mitch Wallace and Matthew J. Wallach on January 12, 2007 and is headquartered in Pleasanton, CA.




In The News:




                            AHM Takes a Prominent Role at the Upcoming Veeva Global Commercial & Medical Summit and Cvent Connect Conferences                            


                            April 28, 2017  •  PR Newswire                        





                            Veeva Vault EDC Now Available to Streamline Trial Design and Execution                            


                            April 25, 2017  •  Business Wire                        





                            Veeva Introduces Vault SiteExchange to Simplify Document Exchange in Clinical Trials                            


                            April 19, 2017  •  Business Wire                        









Veeva Systems, Inc. »
Veeva Systems, Inc. provides industry-specific, cloud-based software solutions for the life sciences industry. Its solutions enable pharmaceutical and other life sciences companies to realize the benefits of modern cloud-based architectures and mobile applications for their most critical business functions, without compromising industry-specific functionality or regulatory compliance. The company's customer relationship management solutions enable its customers to increase the productivity and compliance of their sales and marketing functions. Its regulated content management and collaboration solutions enable its customers to more efficiently manage a regulated, content-centric processes across the enterprise. The company's customer master solution enables customers to more effectively manage complex healthcare provider and healthcare organization data. Veeva Systems was founded by Mark Armenante, Peter P. Gassner, Doug Ostler, Mitch Wallace and Matthew J. Wallach on January 12, 2007 and is headquartered in Pleasanton, CA.






In The News:




 


                                                    AHM Takes a Prominent Role at the Upcoming Veeva Global Commercial & Medical Summit and Cvent Connect Conferences                                                





                                     April 28, 2017  •  PR Newswire                                





 


                                                    Veeva Vault EDC Now Available to Streamline Trial Design and Execution                                                





                                     April 25, 2017  •  Business Wire                                





 


                                                    Veeva Introduces Vault SiteExchange to Simplify Document Exchange in Clinical Trials                                                





                                     April 19, 2017  •  Business Wire                                















You've found a premium RelSci Pro feature!



Connect to Individuals and Organizations In This Story

Upgrade to RelSci Pro to easily sync your contacts and see how you can reach the people and organizations featured in this article.


Start My Free Trial  ➤

Still not convinced? Check out our full listing of features here.



Not Now










Are you a RelSci Pro Subscriber?

Login to RelSci Pro 
                        ➤


Not a Pro Subscriber? Log in here to manage your alerts









 Keep me signed in.
        

Login  ➤



        Forgot your Password?
    

























 I have read the LexisNexis terms & conditions




Sign Me Up  ➤













